Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002488395 | SCV002789618 | uncertain significance | McCune-Albright syndrome; Pseudohypoparathyroidism type 1C; Pseudohypoparathyroidism type 1B; Pseudopseudohypoparathyroidism; Progressive osseous heteroplasia; Pituitary adenoma 3, multiple types; ACTH-independent macronodular adrenal hyperplasia 1; Pseudohypoparathyroidism type I A | 2022-04-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004039388 | SCV004877044 | likely benign | Inborn genetic diseases | 2022-05-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratory of Diagnostic Genome Analysis, |
RCV001572791 | SCV001797705 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001572791 | SCV001974467 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001572791 | SCV001978859 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004536205 | SCV004116531 | uncertain significance | GNAS-related disorder | 2024-06-30 | no assertion criteria provided | clinical testing | The GNAS c.154G>A variant is predicted to result in the amino acid substitution p.Glu52Lys. This variant can also be referred to as precoding variant c.-38308G>A with an alternative transcript (NM_000516). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.041% of alleles in individuals of Latino descent in gnomAD, which is likely too common for an undocumented disease-causing variant. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |